Comparing asthma treatments: switching to a combination inhaler vs adding a daily controller
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study compares two ways to treat asthma: switching from a rescue inhaler (albuterol) to a combination inhaler (albuterol plus budesonide), versus adding a daily controller medication (either a low-dose inhaled steroid or a leukotriene modifier) while continuing albuterol. It aims to see which approach works better for people with asthma who currently use only a rescue inhaler.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of asthma.
- You must have used albuterol (a rescue inhaler) in the past 12 months.
- You should not have taken daily asthma controller medications (like inhaled steroids or leukotriene modifiers) in the past 12 months, unless you are starting one as part of this study.
- You should not have used oral corticosteroids (like prednisone) for asthma or other conditions in the past 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This study compares a three-in-one inhaler (ICS/LABA/LAMA) to a two-in-one inhaler (ICS/LABA) for adults whose asthma is not well-controlled despite using a standard two-in-one inhaler. The goal is to see if the triple inhaler improves asthma control better.
This study tests whether switching to a higher-dose or extrafine triple inhaler helps people whose asthma is still uncontrolled on their current medium-dose combination inhaler. It focuses on improving small-airway function, which may lead to better symptom control.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
This trial compares the safety of two different propellants (the gases that push medicine out of inhalers) in people with well-controlled asthma. Researchers want to ensure both propellants are safe to use in asthma inhalers.
This study tests a new rescue inhaler (Airsupra) for people with asthma after an emergency visit. It may help you manage your asthma at home with fewer side effects.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.